Aspiriant LLC’s Vanguard Total Stock Market ETF VTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.3M Sell
94,327
-65
-0.1% -$21.8K 0.86% 21
2025
Q4
$31.6M Sell
94,392
-1,214
-1% -$404K 0.91% 19
2025
Q3
$31.4M Sell
95,606
-240
-0.3% -$75.8K 0.96% 18
2025
Q2
$29.1M Buy
95,846
+3,579
+4% +$1.01M 0.93% 19
2025
Q1
$25.4M Buy
92,267
+1,179
+1% +$343K 0.88% 17
2024
Q4
$26.4M Sell
91,088
-455
-0.5% -$133K 0.95% 16
2024
Q3
$25.9M Sell
91,543
-765
-0.8% -$209K 0.98% 17
2024
Q2
$24.7M Sell
92,308
-195
-0.2% -$50.5K 1.01% 17
2024
Q1
$24M Buy
92,503
+76
+0.1% +$18.8K 1% 16
2023
Q4
$21.9M Buy
92,427
+49,817
+117% +$11M 0.99% 20
2023
Q3
$9.05M Buy
42,610
+3,282
+8% +$726K 0.46% 33
2023
Q2
$8.66M Sell
39,328
-1,065
-3% -$222K 0.44% 35
2023
Q1
$8.24M Sell
40,393
-2,458
-6% -$492K 0.43% 36
2022
Q4
$8.19M Buy
42,851
+2,191
+5% +$422K 0.42% 34
2022
Q3
$7.3M Buy
40,660
+622
+2% +$124K 0.36% 35
2022
Q2
$7.55M Buy
40,038
+805
+2% +$165K 0.36% 35
2022
Q1
$8.93M Buy
39,233
+54
+0.1% +$12.1K 0.49% 29
2021
Q4
$9.46M Sell
39,179
-4,235
-10% -$1,000K 0.51% 26
2021
Q3
$9.64M Sell
43,414
-272
-0.6% -$62K 0.57% 25
2021
Q2
$9.73M Buy
43,686
+587
+1% +$127K 0.55% 25
2021
Q1
$8.91M Sell
43,099
-891
-2% -$180K 0.57% 25
2020
Q4
$8.56M Sell
43,990
-551
-1% -$101K 0.58% 24
2020
Q3
$7.58M Sell
44,541
-1,478
-3% -$249K 0.59% 27
2020
Q2
$7.21M Buy
46,019
+4,734
+11% +$698K 0.67% 26
2020
Q1
$5.32M Sell
41,285
-18,541
-31% -$2.87M 0.52% 28
2019
Q4
$9.79M Sell
59,826
-2,978
-5% -$467K 0.91% 23
2019
Q3
$9.48M Sell
62,804
-4,423
-7% -$667K 0.85% 24
2019
Q2
$10.1M Buy
67,227
+8,813
+15% +$1.3M 0.84% 26
2019
Q1
$8.45M Buy
58,414
+10,629
+22% +$1.48M 0.69% 31
2018
Q4
$6.1M Buy
47,785
+8,358
+21% +$1.15M 0.46% 38
2018
Q3
$5.9M Sell
39,427
-30
-0.1% -$4.42K 0.5% 40
2018
Q2
$5.54M Buy
39,457
+875
+2% +$122K 0.47% 43
2018
Q1
$5.24M Buy
38,582
+32,551
+540% +$4.56M 0.46% 44
2017
Q4
$828K Sell
6,031
-17,574
-74% -$2.35M 0.24% 39
2017
Q3
$3.06M Buy
23,605
+6,593
+39% +$835K 0.26% 56
2017
Q2
$2.12M Sell
17,012
-1,385
-8% -$171K 0.18% 76
2017
Q1
$2.23M Buy
18,397
+1,289
+8% +$154K 0.19% 78
2016
Q4
$1.97M Sell
17,108
-36
-0.2% -$4.05K 0.18% 74
2016
Q3
$1.91M Buy
17,144
+191
+1% +$21.2K 0.19% 73
2016
Q2
$1.82M Sell
16,953
-2,214
-12% -$235K 0.17% 82
2016
Q1
$2.01M Buy
19,167
+8,658
+82% +$858K 0.19% 70
2015
Q4
$1.1M Sell
10,509
-20,358
-66% -$2.14M 0.12% 43
2015
Q3
$3.22M Buy
30,867
+10,509
+52% +$1.1M 0.27% 29
2015
Q2
$2.18M Buy
20,358
+10,189
+100% +$1.11M 0.21% 26
2015
Q1
$1.09M Hold
10,169
0.14% 38
2014
Q4
$1.08M Buy
10,169
+1,238
+14% +$128K 0.14% 35
2014
Q3
$904K Buy
8,931
+11
+0.1% +$1.13K 0.13% 35
2014
Q2
$908K Sell
8,920
-2,858
-24% -$282K 0.13% 48
2014
Q1
$1.15M Sell
11,778
-708
-6% -$67.8K 0.17% 41
2013
Q4
$1.2M Buy
12,486
+7,598
+155% +$699K 0.19% 35
2013
Q3
$428K Sell
4,888
-2,916
-37% -$253K 0.08% 35
2013
Q2
$645K Buy
+7,804
New +$647K 0.1% 41

Other funds holding VTI

Aspiriant LLC's VTI Position: Q1 2026 in Review

Aspiriant LLC reduced its Vanguard Total Stock Market ETF (VTI) stake by 0.07% in Q1 2026, selling an estimated $21.8K and leaving 94,327 shares worth $30.3M. The position accounts for 0.86% of the portfolio, ranked #21.

Aspiriant LLC first reported a position in VTI in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.6M in Q4 2025. 3,551 funds tracked by Wall St. Rank hold VTI as of Q1 2026.

  • Aspiriant LLC held 94,327 shares of Vanguard Total Stock Market ETF worth $30.3M as of Q1 2026.
  • Aspiriant LLC sold 65 Vanguard Total Stock Market ETF shares in Q1 2026, an estimated $21.8K.
  • Vanguard Total Stock Market ETF made up 0.86% of Aspiriant LLC's portfolio in Q1 2026, its #21 holding.
  • Aspiriant LLC first reported a position in Vanguard Total Stock Market ETF in Q2 2013 and has held it in 52 quarters since.
  • Aspiriant LLC's Vanguard Total Stock Market ETF position peaked at $31.6M in Q4 2025.
  • 3,551 funds tracked by Wall St. Rank held Vanguard Total Stock Market ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.